drugset / Trial / NCT03201562
A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
RandomizedCrossoverTriple-blindTreatment
Summary
To evaluate the safety and efficacy of PRX-100 compared with aceclidine alone and vehicle in the treatment of early to moderate presbyopia.
Timeline
- Start
- 2017-04-30
- Primary completion
- 2018-05-20
- Completion
- 2018-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aceclidine | Small molecule | — | — |
| Subject | tropicamide | Small molecule | — | — |